Descriptions:
Term | description type | Language/acceptability | Language/acceptability | Case significance |
---|---|---|---|---|
Harmful pattern of use of [substance and/or product] (disorder) | FSN | us:P | gb:P | ci |
Harmful pattern of use of [substance and/or product] | SYN | us:P | gb:P | ci |
[substance and/or product] abuse | SYN | us:A | gb:A | ci |
Concept model:
Attribute Group Cardinality | Attribute Cardinality | Attribute cardinality in role group | Attribute | Value |
---|---|---|---|---|
0..0 | 1..1 | |||
0..1 | 0..1 | |||
1..1 | 0..1 | |||
1..1 | ||||
1..1 | 1..1 |
Definition status:
900000000000073002 |Defined (core metadata concept)|
Applies to:
< 1306692000 |Harmful pattern of substance use (disorder)|
Template language
[[~0..1]] {[[~0..1]] 263502005 |Clinical course (attribute)| = [[+id ( < 288524001 |Courses (qualifier value)| ) @course]]},
[[~1..1]]{
[[~0..1]] 246454002 |Occurrence (attribute)| = [[+id ( < 282032007 |Periods of life (qualifier value)| )]],
[[~1..1]] 246075003 |Causative agent (attribute)| = [[ +id (< 105590001 |Substance (substance)| OR < 373873005 |Pharmaceutical / biologic product (product)| )]] }
[[~1..1]]{
[[~1..1]] 363714003 |Interprets (attribute)| = [[ +id (<< 1187057000 |Substance use behavior (observable entity)| ) @interprets]] }
Link to the misaligned concept report:
https://docs.google.com/spreadsheets/d/1nB8paYswgCkbBZERCo7XfPbdmqh7nG2MB857HJDV0nE/edit?gid=0#gid=0
Rules for description generation:
- Apply General rules for generating descriptions for templates;
- Apply Enhancements for the Template Language;
JIRA ticket:
- INFRA-13625Getting issue details... STATUS
EDITORIAL GUIDELINES for Causative agent (attribute):
Hierarchy | Concept type | Allowed | Exception | Examples and Notes |
---|---|---|---|---|
Substance | Base | yes | none | Concepts representing a substance base should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Examples:
Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy. |
Substance | Modification | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
Substance | Structure grouper | yes | none | Concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.
Classification results are expected to be consistent with the modeling of the concept selected as the Causative agent in the Substance hierarchy. |
Substance | Disposition grouper | yes | none | Concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.
Classification results are expected to reflect that the adverse reaction concepts are descendants of the appropriate disposition grouper based on the modeling of the 726542003 |Has disposition (attribute)| attribute in the substance hierarchy. |
Substance | Role grouper | no | none | Concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|.
Classification results are expected to reflect that the adverse reaction concepts are descendants of the appropriate disposition grouper based on the modeling of the 726542003 |Has disposition (attribute)| attribute in the substance hierarchy. |
Product | Medicinal product-containing | yes | none | Examples to be added - pending implementation of roles and products as causative agents |
Product | Role grouper | yes | none | Examples to be added - pending implementation of roles and products as causative agents |
Product | Structure grouper | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. |
Product | Disposition grouper | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. |
Product | Medicinal product-only | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. |
Product | Medicinal product form-containing | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. |
Product | Medicinal product form-only | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. |
Product | Clinical drug | no | none | No use case has been identified for use of this concept type for modeling in this subhierarchy. Medicinal product-containing concepts can be used for modeling in this subhierarchy. |
8 Comments
Farzaneh Ashrafi
Hi Yongsheng Gao
As discussed in today's QI call, here is the draft template for Substance abuse concepts. I anticipate changes to the terming and modelling once the Mental and Behavioural Health Clinical Reference Group has finalized their decision regarding substance use/abuse/ misuse/ dependance etc:
However, as noted during the call, this template can be used as a starting point and to making all current children consistent.
Thanks,
Farzaneh
Yongsheng Gao
Hi Farzaneh Ashrafi , I have updated the format for cardinalities and ranges aligned with template language. Please add the link to the alignment report.
Cheers,
Yong
Farzaneh Ashrafi
Hi Yongsheng Gao
Thanks for the review and update. I added the link to the alignment report.
Thanks,
Farzaneh
Yongsheng Gao
Hi Farzaneh Ashrafi , it looks good. Please go ahead making changes and normalisations. So, we can complete the QI work.
Elaine Wooler
Hi,Farzaneh Ashrafi. Could you please review this and let me know if any changes are needed?
Many thanks
Elaine
Farzaneh Ashrafi
Hi Elaine Wooler
The updated template seems fine to me.
Thanks,
Farzaneh
Elaine Wooler
Hi Yongsheng Gao could you review this template please and see if it is ready to go into production. Thanks.
Yongsheng Gao
Thanks Elaine Wooler it is submitted to the technical team for implementation.